Skip to content

Steve Pakola, Chief Medical Officer at REGENXBIO, sold RGNX on Jul 1, 2026

Data as of Oct 16

▼ SELL$472K36,725 shares at $12.86Steve Pakola Chief Medical OfficerRGNX Regenxbio Inc.
Watch RGNX
Traded
Jul 1, 2026
Disclosed
Jul 1, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Steve Pakola, Chief Medical Officer at REGENXBIO, sold RGNX on Jul 1, 2026TRADEDDISCLOSED
RGNXSimilar stocks (XLV — its sector index fund), rebased to RGNX's price on the disclosure day
RGNX since disclosure
−47.1%
after the sale
Similar stocks (XLV) since disclosure
+10.8%
XLV — its sector index fund

Change in closing price from Jul 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSteve Pakola Chief Medical OfficerRGNX Regenxbio Inc.$216Kdisclosed Jul 1 · filed 2 days after the trade

See every trade on RGNX →